当前位置:
编号:1971518
尼可地尔治疗冠状动脉微血管病变性心绞痛的临床疗效分析
http://www.100md.com 2020年4月11日 《中国实用医药》 2020年第2期
     [4] 韓孝宇, 安建立, 王文广, 等. 尼可地尔联合曲美他嗪对改善老年急性心肌梗死急性PCI术后心功能的作用. 内科急危重症杂志, 2018, 24(6):467-471.

    [5] Parkk JJ, Park SJ, Choi DJ. Microvascular angina: angina that predominantly affects women. Korean J Intern Med, 2015, 30(2):

    140-147.

    [6] 陈贵彬, 张秀红. 尼可地尔联合曲美他嗪治疗微血管性心绞痛的临床疗效. 实用心脑肺血管病杂志, 2017, 25(10):147-149.

    [7] 安国霞, 柴颖儒. 尼可地尔对微血管性心绞痛患者的疗效观察. 临床医药实践, 2018, 27(1): 8-11.

    [8] 吴新旺. 用尼可地尔治疗心绞痛临床疗效的观察. 求医问药, 2012, 10(7):826-827.

    [9] Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol, 1989, 63(21): 18J-24J.

    [10] Treese N, Erbel R, Meyer J. Acute hemodynamic effects of nicorandil in coronary artery disease. J Cardiovasc Pharmacol, 1992, 20(Suppl 3): S52-S56.

    [11] CG Feng, Han B, Liu Y, et al. Effect of nicorandil administration on myocardial microcirculation during primary percutaneous coronary intervention in patients with acute myocardial infarction. Advances in Interventional Cardiology, 2018, 14(1):26-31.

    [12] Kobatake R, Sato T, Fujiwara Y, et al. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels, 2011, 26(4): 379-384.

    [收稿日期:2019-09-19], 百拇医药(及跃 于晓雪 王效增 张磊 鲍丹 王萍 姚莹)